Intellia Therapeutics Inc (NTLA) Sof marja

Intellia Therapeutics (NTLA) brendining ramzi va logotipi

CRISPR texnologiyalaridagi yetakchilik va patent himoyasi Intellia Therapeutics (NTLA) kotirovkalarini qo'llab-quvvatlamoqda, buni savdo marjasi dinamikasi tasdiqlaydi. Biroq, tijorat mahsulotlarining yo'qligi va aksiyalar emissiyasiga tayanib qolish moliyaviy tebranishlarni keltirib chiqarmoqda. Tajribali rahbariyat tizimli ravishda ishlanmalarni tasdiqlash bosqichiga yo'naltirmoqda. -805.80 qiymati ushbu parametr darajasini belgilaydi, bu esa bozor tendentsiyasini baholash uchun joriy daromadlilikni tarixiy ma'lumotlar bilan solishtirish imkonini beradi.

Intellia Therapeutics (NTLA) - Sotuvning sof marjinal rentabelligi 04.07.2022dan 20.11.2026gacha

Intellia Therapeutics kompaniyasining tahliliy kesimlari

- aksiya kursi va ekspertlarning narx prognozi:
Kompaniyaning dastlabki tahlili:Intellia Therapeutics, NTLA
Intellia Corp yetakchi tovari

Intellia Therapeutics (NTLA) kompaniyasining CRISPR/Cas9 patentlari va FDA ning yuqori tartibga soluvchi to'siqlari orqali ta'minlangan monopol maqomi biznesning kelgusidagi daromadliligini belgilaydi. Sof foyda marjasini tahlil qilish orqali investor barcha operatsion xarajatlar va soliqlarni chegirib tashlagandan keyin, har bir dollarlik tushumning qancha qismi foyda ekanligini baholaydi. Ushbu ko'rsatkichdagi ijobiy dinamika intellektual mulkning samarali kapitalizatsiyasi va innovatsiyalarning real naqd pul daromadini tasdiqlaydi.

Intellia Therapeutics raqobatchilari tahlili

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|SRPT - Sotuvning sof marjinal rentabelligi|TWST (Twist Bio) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi TXG|Sof marja Stoke Therapeutics Inc|BLFS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi WVE (Wave Life Sciences Corp)|Kompaniya sotuv marjasi Maze Therapeutics Corp|Sionna Therapeutics Inc - Sof foyda bo'yicha sotuv rentabelligi|PRME (primemedicine.com) - Sof foyda marjasi|TSHA - Sof marja|QURE (uniQure) - Sotuvning sof rentabelligi|MeiraGTx Corp (MGTX) - Sof marja|Regenxbio - Sof foyda normasi|Sof marja solidbio.com|Sof marja ocugen.com OCGN|Sotuvning sof marjinal rentabelligi PACB|Benitec - Sotuvning sof rentabelligi|Sof marja Design Therapeutics DSGN|Sotuvning sof marjinal rentabelligi Rocket Pharmaceuticals RCKT|Sof foyda marjasi 4D Molecular Corp|LXEO: Sof marja|KRRO (Korro Bio, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Editas Medicine (EDIT) - Sotuvning sof marjinal rentabelligi|Sof marja Silence Therapeutics Inc.|Sotuvning sof rentabelligi PRQR (proqr.com)|Sof marja Codexis Bio (CDXS)|Sotuvning sof marjinal rentabelligi sangamo.com (SGMO)|Sof marja nautilus.bio NAUT|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX